Skip to content

Breast diagnostic study by Magnetic Spectroresonance

Accuracy assessment of Breast Spectroscopy by Magnetic Resonance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-9pzj4vz
Enrollment
Unknown
Registered
2025-08-05
Start date
2020-09-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm

Interventions

Qualitative cross-sectional analysis diagnostic study carried out on 80 women over 18 years of age who agreed to participate in the study, referred, by spontaneous demand, to a private imaging diagnos
Chi-square and Student's t-test, with ROC Curve analysis to evaluate the sensitivity and specificity of MRI compared to biopsy results.
V03.175.500

Sponsors

Hospital da Clínicas da Universidade Federal de Goiás
Lead Sponsor
Centro Avançado de Diagnóstico da Mama (CORA)
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women over 18; who agreed to participate in the study and signed the Free and Informed Consent Form; Health Unique System (SUS) users as BI-RADS 4 and 5 with breast anomaly or diagnosed by mammography and/or ultrasound and who have already received a recent diagnosis of breast cancer and who will be referred for incisional, excisional or reexcisional biopsy

Exclusion criteria

Exclusion criteria: Patients who present a high level of claustrophobia as we understand that the patient's non-cooperation could compromise the exam; pacemaker; surgical clips for aneurysms; bearers of neurostimulators; pregnant patients; and patients suffering from gunshot wounds with a projectile lodged and not removed; in addition to a previous history of reaction to gadolinium; women who were not the minimum age required for the study; did not agree to participate in the study or refused to sign the Informed Consent Form

Design outcomes

Primary

MeasureTime frame
Expected outcome: It is expected to find high sensitivity and specificity of breast magnetic resonance spectroscopy applied to the early diagnosis of breast cancer.;Result found: Breast magnetic resonance spectroscopy demonstrated a high accuracy rate of 98% compared to breast biopsy

Secondary

MeasureTime frame
No secondary outcomes were expected

Countries

Brazil

Contacts

Public ContactIlse de Oliveira

Universidade Federal de Goiás

ilsebio@hotmail.com+55(62) 3209-6146

Outcome results

None listed

Source: REBEC (via WHO ICTRP)